Does FUROSEMIDE Cause Malignant neoplasm progression? 62 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Malignant neoplasm progression have been filed in association with FUROSEMIDE (Furosemide). This represents 0.1% of all adverse event reports for FUROSEMIDE.
62
Reports of Malignant neoplasm progression with FUROSEMIDE
0.1%
of all FUROSEMIDE reports
32
Deaths
41
Hospitalizations
How Dangerous Is Malignant neoplasm progression From FUROSEMIDE?
Of the 62 reports, 32 (51.6%) resulted in death, 41 (66.1%) required hospitalization, and 8 (12.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FUROSEMIDE. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does FUROSEMIDE Cause?
Acute kidney injury (7,984)
Hypotension (4,468)
Dyspnoea (3,559)
Fall (3,410)
Drug ineffective (3,297)
Hyponatraemia (3,127)
Hypokalaemia (2,503)
Dehydration (2,195)
Off label use (2,147)
Fatigue (2,107)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which FUROSEMIDE Alternatives Have Lower Malignant neoplasm progression Risk?
FUROSEMIDE vs FUROSEMIDE\SPIRONOLACTONE
FUROSEMIDE vs FUSIDATE
FUROSEMIDE vs FUSIDIC ACID
FUROSEMIDE vs FUTIBATINIB
FUROSEMIDE vs GABAPENTIN